Evidence map›Paper›PMID 35718422›Full record

ReviewHeart failure clinics2022

Training and Career Development in Cardio-Oncology Translational and Implementation Science.

Sherry-Ann Brown, Eric H Yang, Mary Branch, Craig Beavers, Anne Blaes, Michael G Fradley, Richard K Cheng

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heart failure clinics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Cardio-oncology and COVID 19: Lessons learned, past reflections and future deliberations.American heart journal plus : cardiology research and practice · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 7 institutions in 1 country.

Sherry-Ann BrownCardio-Oncology Program, Division of Cardiovascular Medicine, Medical College of Wisconsin, 8701 West Watertown Plank Road, Milwaukee, WI 53226, USA. Electronic address: drbrowncares@gmail.com.
Eric H YangUCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, UCLA Cardiovascular Center, 100 Medical Plaza, Suite 630, Los Angeles, CA 90095, USA. Electronic address: https://twitter.com/datsunian.
Mary BranchSection of Cardiovascular Medicine, Wake Forest University, 1834 Wake Forest Road, Winston- Salem, NC 27109, USA. Electronic address: https://twitter.com/DocBanks84.
Craig BeaversUniversity of Kentucky College of Pharmacy, 40506, 789 South Limestone, Lexington, KY 40508, USA. Electronic address: https://twitter.com/beaverspharmd.
Anne BlaesDivision of Hematology/Oncology, University of Minnesota, 3 Morrill Hall, 100 Church Street Southeast, Minneapolis, MN 55455, USA. Electronic address: https://twitter.com/BlaesAnne.
Michael G FradleyDivision of Cardiology, Department of Medicine, Cardio-Oncology Center of Excellence, Perelman School of Medicine at the University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA.
Richard K ChengCardio-oncology Program, Division of Cardiology, University of Washington, 1959 Northeast Pacific Street, Seattle, WA 98195, USA. Electronic address: https://twitter.com/Richardkcheng2.
Medical College of Wisconsin · USUniversity of California, Los Angeles · USUniversity of Kentucky · USUniversity of Minnesota · USUniversity of Pennsylvania · USUniversity of Washington · USWake Forest University · US

Funding

Clinical and Translational Science AwardUL1TR001436 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI FREED, JULIE K · 2015 to 2025
$47.5M
Institutional Career Development CoreKL2TR001438 · NCATS · MEDICAL COLLEGE OF WISCONSIN · PI WIDLANSKY, MICHAEL E · 2015 to 2024
$2.9M
Impact of L. plantarum 299v supplementation on endothelial function and inflammation in humans with type 2 diabetesK24HL152143 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI WIDLANSKY, MICHAEL E · 2021 to 2025
$572k
NCATS NIH HHS KL2 TR001438NCATS NIH HHS UL1 TR001436NHLBI NIH HHS K24 HL152143
6 · The paper itself

Abstract

Cardiovascular disease is a leading cause of death in cancer survivors, after recurrence of the primary tumor or occurrence of a secondary malignancy. Consequently, the interdisciplinary field of cardio-oncology has grown rapidly in recent years to address the cardiovascular care needs of this unique population through clinical care and research initiatives. Here, the authors discuss the ideal infrastructure for training and career development in cardio-oncology translational and implementation science and emphasize the importance of the multidisciplinary cardiovascular team for both research and patient care. Cardio-oncology training opportunities in general cardiology, hematology/oncology, and specialized cardio-oncology clinical and research fellowships are also considered.

Indexed as

CardiologyCardiovascular DiseasesNeoplasmsHumansImplementation ScienceMedical OncologyCardiologyCardio-oncologyEducationOncologyTrainees

Identifiers

PMID35718422
PMCPMC9236555
OpenAlexW4283012815

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.